Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alya Space designs and deploys large-scale satellite constellations focused on high-resolution earth observation using hyperspectral imaging and synthetic aperture radar. The company’s flagship project involves launching 108 satellites ("Alya‑1 System") to provide near-real-time monitoring with applications in environmental monitoring, agriculture, oil & gas exploration, disaster response, and more. The first launches were scheduled for March 2024 from Jiu Quan, China. They have signed major contracts with Hong Kong Aerospace Technology Group (~$675 million) for manufacturing and deployment support. The company has also partnered with Vaya Space for launch services. Led by CEO Aila Raquel. Focused on Brazil and Europe as primary markets. Not involved in drug development or healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alya Space.